T. Lynn Redford

T. Lynn Redford has over 28 years of work experience, primarily in the pharmaceutical industry. T. Lynn is currently working as an Oncology Sales Account Manager at G1 Therapeutics, Inc. since November 2021. Prior to this, they worked as an Oncology Account Manager at Oncopeptides AB from September 2020 to November 2021.

Their longest tenure was with Celgene/BMS, where they started as an Executive Hematology Consultant in August 2007 and remained until September 2020. During their time at Celgene/BMS, they achieved significant recognition, receiving the Diamond Club Award (Top 15%) in 2019, 2014, 2010, and 2008. In 2010, they were selected to be the Istodax Lead in the Little Rock District, leading the launch of a new lymphoma product in three states.

Before Celgene/BMS, they worked as an Oncology Sales representative at MGI Pharma from February 2006 to July 2007. Prior to that, they worked at Pfizer, initially with Genentics Institute, which was later acquired by Wyeth Oncology, and then by Pfizer. T. Lynn started their career at Pfizer in February 2003 and remained with the company until February 2006.

Earlier in their career, they held the role of Oncology Account Manager at Wyeth Oncology from September 2001 to February 2003. Before that, they worked as a District Sales Manager at Takeda from March 1999 to September 2001. Their career began at Bayer, where they worked in sales from 1993 to 1999.

Throughout their work experience, T. Lynn Redford has gained expertise in oncology sales and account management.

T. Lynn Redford began their education journey at the Haslam College of Business at the University of Tennessee in 1984. T. Lynn completed their Bachelor of Science (BS) degree with a focus on Accounting, Finance, and Statistics, graduating with honors in 1988.

Following their undergraduate studies, T. Lynn Redford pursued further education at Liberty University. Unfortunately, the exact duration of their enrollment and completion of a Master of Arts (MA) degree in History remains unknown as the start and end years were not provided.